ZA88562B - Mixed micelle solutions - Google Patents

Mixed micelle solutions

Info

Publication number
ZA88562B
ZA88562B ZA880562A ZA88562A ZA88562B ZA 88562 B ZA88562 B ZA 88562B ZA 880562 A ZA880562 A ZA 880562A ZA 88562 A ZA88562 A ZA 88562A ZA 88562 B ZA88562 B ZA 88562B
Authority
ZA
South Africa
Prior art keywords
mixed micelle
micelle solutions
solutions
inflammatories
solubilization
Prior art date
Application number
ZA880562A
Other languages
English (en)
Inventor
Ferro Alberto
Steffen Hans
Original Assignee
F. Hoffmann-La Roche & Co. Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche & Co. Aktiengesellschaft filed Critical F. Hoffmann-La Roche & Co. Aktiengesellschaft
Publication of ZA88562B publication Critical patent/ZA88562B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA880562A 1987-02-03 1988-01-27 Mixed micelle solutions ZA88562B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH38087 1987-02-03

Publications (1)

Publication Number Publication Date
ZA88562B true ZA88562B (en) 1988-08-03

Family

ID=4185694

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA880562A ZA88562B (en) 1987-02-03 1988-01-27 Mixed micelle solutions

Country Status (13)

Country Link
US (1) US4882164A (ja)
EP (1) EP0280887B1 (ja)
JP (1) JP2645427B2 (ja)
AT (1) ATE71288T1 (ja)
AU (1) AU599198B2 (ja)
CA (1) CA1319886C (ja)
DE (1) DE3867502D1 (ja)
DK (1) DK175662B1 (ja)
ES (1) ES2040278T3 (ja)
IE (1) IE61068B1 (ja)
NZ (1) NZ223290A (ja)
PH (1) PH24848A (ja)
ZA (1) ZA88562B (ja)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3903753A1 (de) * 1989-02-06 1990-08-23 Schering Ag Verfahren zur herstellung waessriger mischmicelloesungen
NZ232865A (en) * 1989-03-21 1992-07-28 Hoffmann La Roche A mixed-micelle solution comprising a micelle former and an immunomodulator
AU6461090A (en) * 1989-10-30 1991-05-02 Abbott Laboratories Injectable formulation for lipophilic drugs
US5085864A (en) * 1989-10-30 1992-02-04 Abbott Laboratories Injectable formulation for lipophilic drugs
DE3938030A1 (de) * 1989-11-13 1991-05-16 Schering Ag Verfahren zur herstellung waessriger mischmicelloesungen
CA2033725C (en) * 1990-01-24 2001-05-29 Folker Pittrof Pharmaceutical and cosmetic compositions containing a salt of cholanic acid
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
JP3249147B2 (ja) * 1990-06-01 2002-01-21 キリン−アムジエン・インコーポレーテツド 生理活性蛋白含有経口製剤
FR2663224B1 (fr) * 1990-06-14 1995-01-20 Applicationes Farmaceuticas Sa Forme galenique parenterale.
FR2715846A1 (fr) * 1994-02-07 1995-08-11 Rhone Poulenc Rorer Sa Nouvelle composition pharmceutique à base de taxoïdes.
JP2740153B2 (ja) * 1995-03-07 1998-04-15 エフ・ホフマン−ラ ロシユ アーゲー 混合ミセル
DE19522693A1 (de) * 1995-06-22 1997-01-02 Dianorm G Maierhofer Gmbh Zusammensetzung zur Herstellung feindisperser Systeme und Verfahren zu ihrer Herstellung
US5891472A (en) * 1996-11-19 1999-04-06 Meri Charmyne Russell Treatment of equine laminitis
GB9625589D0 (en) 1996-12-10 1997-01-29 Boots Co Plc Therapeutic agents
DZ2479A1 (fr) * 1997-05-05 2003-02-01 Pfizer Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant.
US20030212123A1 (en) * 1997-05-05 2003-11-13 Pfizer Inc. COX-2 selective carprofen for treating pain and inflammation in dogs
AU773615B2 (en) * 1997-05-05 2004-05-27 Pfizer Inc. COX-2 selective carprofen for treating pain and inflammation in dogs
CH692322A5 (it) * 1997-05-26 2002-05-15 Westy Ag Formulazione iniettabile limpida di Propofol.
WO1999043301A1 (en) * 1998-02-24 1999-09-02 The Board Of Trustees Of The University Of Illinois Lipid emulsions in the treatment of systemic poisoning
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
US20060014674A1 (en) * 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
SE0100901D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab New composition
US20040132823A1 (en) * 2001-11-02 2004-07-08 Leo Pavliv Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
US20030190343A1 (en) * 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals
GB0207529D0 (en) * 2002-04-02 2002-05-08 Norbrook Lab Ltd Injectable veterinary composition for small animals
CA2521603A1 (en) * 2003-04-07 2004-10-21 Jurox Pty Ltd Stable carprofen composition
AU2004260695C1 (en) * 2003-07-31 2008-12-11 Board Of Regents, The University Of Texas System Sterile preparations of phospholipids and anti-inflammatory pharmaceuticals and methods for making and using same
JP2009517410A (ja) * 2005-11-30 2009-04-30 ジェネレクス ファーマシューティカルズ インコーポレイテッド 経口吸収される医薬製剤および投与方法
WO2008135828A2 (en) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
US8703204B2 (en) 2007-05-03 2014-04-22 Bend Research, Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
KR100785656B1 (ko) 2007-05-14 2007-12-17 재단법인서울대학교산학협력재단 소염제로 사용되는 소디움글리코콜레이트 또는 그 유도체
EP2162120B1 (en) 2007-06-04 2016-05-04 Bend Research, Inc Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
WO2009073215A1 (en) 2007-12-06 2009-06-11 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
US9233078B2 (en) 2007-12-06 2016-01-12 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
HUE039967T2 (hu) 2009-11-23 2019-02-28 Cubist Pharmaceuticals Llc Lipopeptid kompozíció és ezzel kapcsolatos eljárások
WO2013081120A1 (ja) * 2011-11-30 2013-06-06 学校法人日本大学 レシチンオルガノゲル形成剤
EP2857043B1 (en) * 2012-05-31 2019-01-23 Terumo Kabushiki Kaisha pH-SENSITIVE CARRIER AND METHOD FOR PRODUCTION THEREOF, pH-SENSITIVE MEDICINE AND pH-SENSITIVE PHARMACEUTICAL COMPOSITION EACH CONTAINING SAID CARRIER, AND CULTURE METHOD USING SAID pH-SENSITIVE MEDICINE OR SAID pH-SENSITIVE PHARMACEUTICAL COMPOSITION
CN105792843B (zh) * 2013-11-29 2020-02-28 泰尔茂株式会社 佐剂组合物及包含其的疫苗组合物、以及它们的制造方法
US20170035701A1 (en) * 2015-08-04 2017-02-09 Taipei Medical University Stabilized high drug load nanocarriers, methods for their preparation and use thereof
US9937147B2 (en) * 2015-10-29 2018-04-10 NBDD, Inc. Edible base product composition
WO2018129345A1 (en) 2017-01-08 2018-07-12 Resq Pharma, Inc. Methods for decreasing injuries associated with intraoperative hypotension
CN110169951A (zh) * 2019-05-17 2019-08-27 河北远征药业有限公司 一种兽用卡洛芬注射液及其制备方法和应用
CN110025575A (zh) * 2019-05-24 2019-07-19 安徽奥力欣生物科技有限公司 一种替米考星混合胶束可溶性粉及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL260444A (ja) * 1960-12-05
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
IT1202370B (it) 1976-07-12 1989-02-09 Hoffmann La Roche Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti
GR73668B (ja) * 1978-11-21 1984-03-28 Hoffmann La Roche
US4328222A (en) * 1978-11-21 1982-05-04 Hoffmann-La Roche Inc. Pharmaceutical compositions for parenteral or local administration
DE2914788A1 (de) * 1979-04-11 1980-10-16 Nattermann A & Cie Parenteral applizierbare, stabile arzneimittelloesungen mit entzuendungshemmender wirkung
SE8002660L (sv) * 1979-04-14 1980-10-15 Hanning Elektro Werke Maskin for skerpning av skerverktyg eller annat slipgods
DE3221579A1 (de) * 1982-06-08 1983-12-22 Eckert, Theodor, Prof. Dr., 4400 Münster Solubilisierung von in wasser schwerloeslichen wirkstoffen in waessrige loesung unter verwendung eines gemisches von cholinphosphorsaeureglycerindiester (cholin-lecithin) und natriumdesoxycholat als loesungsvermittler und die therapeutische verwendung der so erhaltenen waessrigen loesungen
IL72420A (en) * 1983-07-22 1987-10-30 Hoffmann La Roche Aqueous vitamin e solutions and their manufacture
CA1264162A (en) 1984-03-15 1990-01-02 Manfred Breuninger Glycerol ether phosphatides
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung

Also Published As

Publication number Publication date
IE61068B1 (en) 1994-09-21
ATE71288T1 (de) 1992-01-15
IE880279L (en) 1988-08-03
EP0280887B1 (de) 1992-01-08
DK4088A (da) 1988-08-04
DK4088D0 (da) 1988-01-06
JPS63201133A (ja) 1988-08-19
AU599198B2 (en) 1990-07-12
JP2645427B2 (ja) 1997-08-25
AU1076688A (en) 1988-08-04
DE3867502D1 (de) 1992-02-20
US4882164A (en) 1989-11-21
ES2040278T3 (es) 1993-10-16
NZ223290A (en) 1990-11-27
CA1319886C (en) 1993-07-06
EP0280887A1 (de) 1988-09-07
DK175662B1 (da) 2005-01-10
PH24848A (en) 1990-12-26

Similar Documents

Publication Publication Date Title
ZA88562B (en) Mixed micelle solutions
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
ES554967A0 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
ES2037385T3 (es) Un procedimiento de manufactura de una preparacion farmaceutica para administracion local.
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
ES2061799T3 (es) Nuevo preparado medicamentoso y procedimiento para su preparacion.
DE3776946D1 (de) Nasale verabreichung von arzneimitteln.
NZ236823A (en) Topical pharmaceutical and cosmetic compositions containing a salt of cholanic acid, a lipid and optionally a pharmaceutically or cosmetically active substance
AR240250A1 (es) Procedimiento para la preparacion de una nueva formualcion farmaceutica oral que contiene omeprazol como ingrediente activo.
AU2506388A (en) Azelastine-containing medicaments for application in the nose and/or at the eye
ES2074124T3 (es) Composicion en forma de una espuma que contiene acido 5-aminosalicilico para administracion intra-rectal.
NO177177C (no) Fremgangsmåte for fremstilling av en flytende doseringsform for oral administrasjon av en farmasöytisk substans
ES551119A0 (es) Procedimiento para preparar un agente analgesicamente activo a base de 2-amino-3-carboetoxiamino-6-(4-fluorobencilamino)-piridina y por lo menos un agente antiflogistico no esteroidal
AU1935788A (en) A process for producing an administration and/or dosage form for medically active ingredients of drugs
EP0177342A3 (en) Oral formulation of therapeutic proteins
PT97476A (pt) Processo de preparacao de composicoes farmaceuticas para distribuicao sub-lingual de medicamentos a base de, entre outros, calcitonina, hormona de crescimento humano ou nifedipina
ES2059312T3 (es) Medicamento que puede administrarse por via nasal, procedimiento para su preparacion y su aplicacion.
ATE87467T1 (de) Pharmazeutische zubereitung.
ATE5073T1 (de) 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
MY110074A (en) Pharmacuetical formulation.
GR3029886T3 (en) Method of preparing a radioactive rhenium complex solution.
PT742716E (pt) Composicao farmaceutica para administracao transdermica sistemica contendo a substancia activa morfina-6-glucuronido
AU1128783A (en) Thiazaspirane derivatives
ES2032476T3 (es) Un procedimiento para preparar nuevos derivados de 2-anilinotiazolina.
EP0389773A3 (de) Verfahren zur Herstellung einer Galenischen Zubereitung mit optimaler Bioverfügbarkeit des Wirkstoffs 2-Hydroxy-5-methyllaurophenonoxime (HMLO)